Lemtrada hasn’t proven to help against disability in the treatment of relapsing multiple sclerosis, said U.S. advisers who questioned whether the company’s studies were conducted well enough to assess the drug.
While the U.S. Food and Drug Administration advisory panel decided that potential safety risks don’t preclude approval of Lemtrada, its members voted 14-2 that the drug didn’t help improve a patient’s disability. The agency isn’t required to accept the recommendations of its advisers..... Read More - http://www.ms-uk.org/lemtrada
MS drug Lemtrada does not benefit patients, FDA panel says
MS drug Lemtrada does not benefit patients, FDA panel says
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1032 Views
-
Last post by NHE
-
- 0 Replies
- 1072 Views
-
Last post by ElliotB
-
- 0 Replies
- 1710 Views
-
Last post by CureIous
-
- 0 Replies
- 1535 Views
-
Last post by frodo
-
- 0 Replies
- 1530 Views
-
Last post by NHE
-
- 0 Replies
- 480 Views
-
Last post by NHE
-
- 0 Replies
- 1656 Views
-
Last post by NHE
-
- 1 Replies
- 3122 Views
-
Last post by Tif
-
- 0 Replies
- 2416 Views
-
Last post by frodo